Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000246521 | SCV000320344 | likely benign | Cardiovascular phenotype | 2019-10-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000461700 | SCV000555788 | benign | Arrhythmogenic cardiomyopathy with wooly hair and keratoderma; Arrhythmogenic right ventricular dysplasia 8 | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000038096 | SCV000700572 | likely benign | not specified | 2016-11-30 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000038096 | SCV000919295 | likely benign | not specified | 2018-04-23 | criteria provided, single submitter | clinical testing | Variant summary: DSP c.8117_8119delAGA (p.Lys2706del) results in an in-frame deletion that is predicted to remove one amino acid from the encoded protein. The variant allele was found at a frequency of 0.00057 in 277174 control chromosomes. The observed variant frequency is approximately 57 fold above the estimated maximal expected allele frequency for a pathogenic variant in DSP causing Arrhythmia phenotype (1e-05), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.8117_8119delAGA in individuals affected with Arrhythmia and no experimental evidence demonstrating its impact on protein function have been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014: one VUS, one likely benign, and one benign. Based on the evidence outlined above, the variant was classified as likely benign. |
Center for Advanced Laboratory Medicine, |
RCV000852998 | SCV000995752 | likely benign | Cardiomyopathy | 2018-06-26 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000852998 | SCV001353200 | likely benign | Cardiomyopathy | 2018-11-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001571521 | SCV001796014 | likely benign | not provided | 2020-02-13 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001571521 | SCV003799618 | likely benign | not provided | 2022-08-16 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003934918 | SCV004754061 | likely benign | DSP-related condition | 2019-11-08 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Laboratory for Molecular Medicine, |
RCV000038096 | SCV000061762 | uncertain significance | not specified | 2014-01-30 | no assertion criteria provided | clinical testing | proposed classification - variant undergoing re-assessment, contact laboratory |